Galderma Group AG/Fr. GALD
07:00
09:05
11:10
13:15
15:20
1D1W1MYTD1Y5YMAX
About Galderma Group AG
Galderma Group AG is a global dermatology company specializing in the research, development, and marketing of medical solutions in skin health. The company operates in the pharmaceuticals, medical devices, and consumer products segments, offering treatments for conditions like acne, rosacea, psoriasis, and other dermatological ailments. Founded in 1981 and headquartered in Lausanne, Switzerland, Galderma leverages an extensive global network to distribute its products across various regions. The company's strategic focus on dermatology enables it to maintain a robust portfolio of targeted therapies and skincare solutions that address both medical and aesthetic needs.
Ticker
Fr. GALD
Sector
Primary listing
XSWX
Employees
7,676
Headquarters
Zug, Switzerland
Website
GALD Metrics
BasicAdvanced
CHF 37bn
77.63
CHF 2.04
-
CHF 0.35
0.22%
Price and volume
Market cap
CHF 37bn
52-week high
CHF 170.10
52-week low
CHF 94.70
Average daily volume
540k
Dividend rate
CHF 0.35
Financial strength
Current ratio
1.186
Quick ratio
0.896
Long term debt to equity
32.998
Total debt to equity
33.796
Dividend payout ratio (TTM)
6.69%
Interest coverage (TTM)
5.12%
Profitability
EBITDA (TTM)
897.708
Gross margin (TTM)
68.86%
Net profit margin (TTM)
11.70%
Operating margin (TTM)
16.89%
Effective tax rate (TTM)
4.07%
Revenue per employee (TTM)
CHF 538,300
Management effectiveness
Return on assets (TTM)
4.25%
Return on equity (TTM)
7.69%
Valuation
Price to earnings (TTM)
77.629
Price to revenue (TTM)
9.008
Price to book
4.58
Price to tangible book (TTM)
-23.07
Price to free cash flow (TTM)
45.79
Free cash flow yield (TTM)
2.18%
Free cash flow per share (TTM)
3.463
Dividend yield (TTM)
0.22%
Growth
Revenue change (TTM)
18.04%
Earnings per share change (TTM)
165.98%
3-year revenue growth (CAGR)
11.08%
3-year earnings per share growth (CAGR)
411.24%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Galderma Group AG stock?
Galderma Group AG (GALD) has a market cap of Fr.37B as of April 30, 2026.
What is the P/E ratio for Galderma Group AG stock?
The price to earnings (P/E) ratio for Galderma Group AG (GALD) stock is 77.63 as of April 30, 2026.
Does Galderma Group AG stock pay dividends?
Yes, the Galderma Group AG (GALD) stock pays dividends to shareholders. As of April 30, 2026, the dividend rate is Fr.0.35 and the yield is 0.22%. Galderma Group AG has a payout ratio of 6.69% on a trailing twelve-month basis.
When is the next Galderma Group AG dividend payment date?
The next Galderma Group AG (GALD) dividend payment date is unconfirmed.
What is the beta indicator for Galderma Group AG?
Galderma Group AG (GALD) does not currently have a Beta indicator.